Healthscope Limited: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial ReportiCD ResearchFebruary 2, 2012 30 Pages - SKU: ICDR6792558 |
| Synopsis ICD Research's Healthscope Limited: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company. Summary ICD Research's Healthscope Limited: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report is a crucial resource for industry executives and anyone looking to access key information about Healthscope Limited. ICD Research's Healthscope Limited: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope
Healthscope Limited (Healthscope) one of the leading private healthcare services providers in Australia. The company operates private hospitals and medical centers in Australia. It also provides pathology testing services both in Australia and internationally. The company operates through three business segments: Hospitals Australia, Pathology Australia and Pathology International. Its subsidiaries include Healthscope (Tasmania) Pty Ltd, Healthscope South Australia Pty Ltd, Healthscope (Tasmania Finance) Pty Ltd, Maybury Craft Pty Ltd, Darwin Private Hospital Pty Ltd and The Victorian Rehabilitation Centre Pty Ltd. The company operates in Australia, New Zealand, Singapore and Malaysia. Healthscope is headquartered in Parkville, Victoria, Australia. |
Related Markets
Pharmaceuticals Company Reports
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012
- Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
- Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
- Partnerships, Licensing, Investments and M&A Deals and Trends for March 2012 in Pharmaceuticals
- Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

